Insight on Pharmaceuticals and Healthcare in Europe

Published within

« | ... | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | ... | » »|

Type Product title / description Pub Price
Report
Report

R&D Trends: Systemic Lupus Erythematosus - Benlysta’s FDA approval provides hope for disease treatment, future trial design, and other pipeline candidates

Review of candidates in development for systemic lupus erythematosus (SLE) across the seven major markets, highlighting key trends, as well as detailed analyses of clinical trial design, innovative early-stage projects and future treatment.

Published By Datamonitor
26 May 2011 $2800
Buy
Report
Report

R&D Trends: Skin and soft tissue infections - MRSA threat drives R&D interest in an increasingly fragmented market

The emergence of methicillin-resistant Staphylococcus aureus (MRSA) has driven R&D interest in skin and soft tissue infections (SSTIs). This module reviews pipeline trends, clinical trial design, and future treatment paradigms for SSTIs.

Published By Datamonitor
05 Jul 2011 $2800
Buy
Report
Report

R&D Trends: Sepsis - Improvements in clinical trial design and advances in biomarker research hold the key to a tailored approach to sepsis therapy

Progress in sepsis drug development has been severely hindered by the complex disease pathogenesis and patient heterogeneity. This module reviews pipeline trends, clinical trial design, and future treatment paradigms for sepsis.

Published By Datamonitor
06 Apr 2011 $2800
Buy
Report
Report

R&D Trends: Rheumatoid Arthritis – Approaching an era of novel kinase inhibitors

Review of candidates in development for rheumatoid arthritis across the seven major markets, highlighting key trends, as well as analyses of clinical trial design, innovative early-stage projects and hypothesizing on how future treatment may evolve.

Published By Datamonitor
01 Jul 2011 $2800
Buy
Report
Report

R&D Trends: Renal Cell Cancer – Crowded RCC market remains attractive to drug developers

Review of key R&D trends in renal cell cancer including; dynamics of the pipeline, comparator therapies, target product profile, trends in clinical trial design, innovative early-stage projects, and the future of colorectal cancer treatment.

Published By Datamonitor
09 Aug 2012 $2800
Buy

Order this report by 20th May 2011 and receive a 15% discount

To take advantage of this offer enter Promo Code CMDN17 when prompted in the checkout

More information

Report
Report

R&D Trends: Psoriasis - Pipeline outlook following withdrawal of key regulatory filing

Review of candidates in development for psoriasis across the seven major markets, highlighting key trends, as well as detailed analyses of clinical trial design, innovative early-stage projects and hypothesizing on how future treatment may evolve

Published By Datamonitor
16 Mar 2011 $2800
Buy
Report
Report

R&D Trends: Prostate Cancer - Newly approved therapies shift treatment dynamics for castrate-resistant disease

Review of key R&D trends in prostate cancer including; dynamics of the pipeline, comparator therapies, target product profile, trends in clinical trial design, innovative early-stage projects, and the future of prostate cancer treatment.

Published By Datamonitor
17 Jun 2011 $2800
Buy
Report
Report

R&D Trends: Parkinson's Disease – Pipeline swells but a paradigm shift is unlikely in the mid-term

Review of key trends in the development of new Parkinson’s disease drugs across the seven major markets. Includes detailed analyses of the composition of the pipeline, clinical trial design, target product profile, and future treatment developments.

Published By Datamonitor
15 Jun 2012 $2800
Buy
Report
Report

R&D Trends: Osteoporosis - Strong pipeline bodes well for future treatment

Review of key trends in the development of new osteoporosis drugs across the seven major markets. Also includes detailed analyses of clinical trial design, target product profile, innovative early-stage projects, and future treatment developments

Published By Datamonitor
01 Nov 2011 $2800
Buy
Report
Report

R&D Trends: Obesity - 2006–2011: obesity’s lean years

Datamonitor module assesses the current state of the obesity pipeline and trends that will shape its future. Focused on the US, Japan, France, Germany, Italy, Spain, and the UK

Published By Datamonitor
11 May 2011 $2800
Buy

« | ... | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | ... | » »|

No help is available.